Prophylactic and therapeutic strategies in chemotherapy-induced neutropenia

Risk and Timing of Neutropenic Events in Adult Cancer Patients Receiving Chemotherapy: The Results of a Prospective Nationwide Study of Oncology Practice

(2017) Jeffrey Crawford et al.   Journal of the National Comprehensive Cancer Network

Prevention and Treatment of Cancer-Related Infections

(2017)   Journal of the National Comprehensive Cancer Network

Acute Myeloid Leukemia or Myelodysplastic Syndrome in Randomized Controlled Clinical Trials of Cancer Chemotherapy With Granulocyte Colony-Stimulating Factor: A Systematic Review

(2010) Gary H. Lyman et al.   JOURNAL OF CLINICAL ONCOLOGY

Management of chemotherapy-associated febrile neutropenia

(2009) D Cameron   BRITISH JOURNAL OF CANCER

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

New therapies for fungal pneumonia

(2009) Johan Maertens et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction

(2008) Jaffer A. Ajani   CANCER

Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: Results from an integrated analysis

(2008) G. von Minckwitz et al.   EUROPEAN JOURNAL OF CANCER

Induction Therapy in the Modern Era of Combined-Modality Therapy for Locally Advanced Head and Neck Cancer

(2008) Marshall Posner et al.   SEMINARS IN ONCOLOGY

Pegfilgrastim   ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study

(2007) G. von Minckwitz et al.   ANNALS OF ONCOLOGY